Granite Point Capital Management, L.P. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 63 filers reported holding XENON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$611,000
-21.8%
20,000
-20.0%
0.13%
-3.0%
Q4 2021$781,000
-61.9%
25,000
-77.3%
0.13%
+73.7%
Q2 2021$2,048,000
+63.4%
110,000
+57.1%
0.08%
+61.7%
Q1 2021$1,253,000
-41.5%
70,000
-49.8%
0.05%
-57.3%
Q4 2020$2,143,000
+36.7%
139,360
-1.6%
0.11%
+29.4%
Q3 2020$1,568,000
-11.7%
141,6600.0%0.08%
-5.6%
Q2 2020$1,776,000
+10.6%
141,6600.0%0.09%
-90.1%
Q1 2020$1,606,000
-55.1%
141,660
-48.0%
0.91%
+62.5%
Q4 2019$3,573,000
+33.8%
272,543
-8.1%
0.56%
+33.5%
Q3 2019$2,671,000
-10.7%
296,500
-2.2%
0.42%
+106.9%
Q2 2019$2,991,000
-3.0%
303,3000.0%0.20%
-32.2%
Q1 2019$3,082,000
+92.9%
303,300
+19.7%
0.30%
-7.7%
Q4 2018$1,598,000
-73.9%
253,300
-45.4%
0.32%
-20.6%
Q3 2018$6,129,000
+38.2%
464,300
-3.7%
0.41%
+2.5%
Q2 2018$4,436,000482,2000.40%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,594,932$48,518,00010.26%
GREAT POINT PARTNERS LLC 1,104,334$33,594,0008.06%
ACUTA CAPITAL PARTNERS, LLC 272,500$8,289,0004.62%
DAFNA Capital Management LLC 438,623$13,343,0003.64%
Parkman Healthcare Partners LLC 294,559$8,960,0003.30%
Avoro Capital Advisors LLC 4,900,000$149,058,0002.94%
Nan Fung Group Holdings Ltd 114,380$3,479,0002.39%
BVF INC/IL 1,597,966$48,610,0002.35%
SILVERARC CAPITAL MANAGEMENT, LLC 232,630$7,077,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,391,038$133,575,0002.16%
View complete list of XENON PHARMACEUTICALS INC shareholders